WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4701 Infant (under 12 months) mortality rate: 612
GDP / capita (US$): 1'2071 Child (under 5 years) mortality rate: 942

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 12'396  12'092  11'806  11'537  11'281  8'809  6'041  4'512 
Births 447  442  436  431  426  378  289  216 
Surviving infants 422  416  410  404  398  338  250  180 
Pop. less than 5 years 1'983  1'949  1'917  1'891  1'866  1'540  1'080  780 
Pop. less than 15 years 5'264  5'157  5'059  4'966  4'876  3'897  2'646  1'886 
Female 15-49 years 2'887  2'806  2'729  2'658  2'591  1'990  1'365  1'059 

Number of reported cases

(Click for retrospective incidence data for Guinea)
Diphtheria
ChartChart
  37 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  316  243  175  53  11'294  12'756  8'552 
Mumps
ChartChart
 
Pertussis
ChartChart
  247  412  2'315 
Polio*
ChartChart
  155  32 
Rubella
ChartChart
  289  10  55 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  113  75  51  245  53 
Tetanus (total)**
ChartChart
  113  75  51  245  524  482 
Yellow fever
ChartChart
  445 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guinea)
Vaccine year result method % card seen                                                
BCG 2011  82  DHS/MICS   44  86  75  82  95  84  71  50 
DTP1 2011  76  DHS/MICS   44  80  70  75  95  99*  67 
DTP3 2011  50  DHS/MICS   44  66  60  60  90  99*  57  20 
DTP4         
IPV1          66  47 
HepB_BD         
HepB3 2011  50  DHS/MICS   44  66  60  60  90  99* 
Hib3 2011  50  DHS/MICS   44  66  60  60  90  99* 
JapEnc         
MCV1          64  60  62  90  99*  59  25 
MCV2         
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2011  51  DHS/MICS   44  72  60  60  90  97  57  20 
Rota1         
RotaC         
RCV1         
TT2plus 2011  71  DHS/MICS   44  60  54  62  93  86  43  21 
PAB          67 
VAD1          33  80 
YFV 2011  38  DHS/MICS   44  63  60  62  90  99* 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guinea)
BCG
ChartChart
  72  72  72  82  74  81  50 
DTP1
ChartChart
  65  63  60  76  76  61  40 
DTP3
ChartChart
  57  54  51  63  62  46  17 
HepB3
ChartChart
  57  54  51  63  62 
HepB_BD
ChartChart
 
Hib3
ChartChart
  57  54  51  63  62 
IPV1
  57 
MCV1
ChartChart
  54  53  52  62  61  42  35 
MCV2
 
PCV3
 
Pol3
ChartChart
  42  42  42  63  63  47  18 
RCV1
 
RotaC
 
YFV
ChartChart
  54  54  53  63  62 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 38  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 58
From 80 to 89% 29
From 50 to 79% 13
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV girls 9-13 years; Yes Demo - from 2019
IPV 14 weeks; Yes
Measles 9 months; Yes
MenA Yes From 2018
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj Yes From 2017
Rotavirus Yes From 2018
TT 1st contact; +1, +6 months; +1, +1 years; Yes 15-49 years
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2011-2015  2011-2015  2011-2015  2011-2015  2011- 2015  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 38  38  38  38  38  38  38 

System performance

Total Nº districts in country number 38  38  38  38  38  38  38 
Nº districts with DTP3 coverage >=80% number 33  28  14  35  37  33  27 
% of districts with DTP3 coverage >=80% From 0 to 100% 87  74  37  92  97  87  71 
Nº districts with measles (MCV1) coverage >=95% number 24  16  19  23  18  21  10 
% of districts with MCV1 coverage >=95% From 0 to 100% 63  42  50  61  47  55  26 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%   31      49 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.